Loading
Mark Coles

Mark Coles

Professor of Immunology, University of Oxford

Mark Coles is a Professor of Immunology at the Kennedy Institute of Rheumatology, affiliated faculty in the Wolfson Centre of Mathematical Biology  and member of the MRC Centre of Excellence in Exposome Immunology at the University of Oxford. 

He is the co-founder of Mestag Therapeutics and Lightox Ltd.  Research in his group focuses on the application of human experimental medicine to immune mediated inflammatory disease. 

Sessions